HHS ▲ +0.6% - Harte Hanks, Inc. $HHS issues new initiatives to reduce animal testing in drug development - STAT Harte Hanks rose 0.6% following news that the company is launching new initiatives to reduce animal testing in drug development. The move suggests investor confidence in the company's efforts to address regulatory and ethical concerns in the pharmaceutical development process. 22-SEP-2026 03:29 PM ET